ArticleTranslational pediatrics2026
Comparative evaluation of seven large language models in providing home phototherapy care guidance for neonatal hyperbilirubinemia.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal hyperbilirubinemia affects 60-80% of term newborns. The American Academy of Pediatrics (AAP) recommends that infants with elevated bilirubin after discharge who meet specific criteria can receive home phototherapy to preserve family bonding. Despite caregivers increasingly seeking online health information, no research has evaluated large language models (LLMs) as auxiliary guidance tools for home phototherapy. This study aimed to comparatively evaluate seven mainstream LLMs as auxiliary educational tools for guiding caregivers in home phototherapy management, identifying which models provide reliable operational guidance versus those presenting safety risks. Methods: Seven high-ranking LLMs were selected: ChatGPT-4o, Copilot, Gemini 1.5 Flash, Claude 3.5 Sonnet, DeepSeek-R1, GLM-4, and ERNIE 4.0 Turbo. We developed a 15-item questionnaire covering seven domains based primarily on AAP neonatal hyperbilirubinemia guidelines. Each LLM received three priming prompts followed by 15 caregiver-perspective questions. Two investigators independently queried each model (November 2024-February 2025). Three board-certified neonatologists blindly evaluated 210 responses using modified Likert scales across five dimensions: accuracy, completeness, reproducibility, empathy, and readability. Expert clinician responses served as the "gold standard" and benchmarks. Results: DeepSeek-R1 demonstrated superior performance across all dimensions (total score: 19.31/20), with 87.8% of responses rated as "completely correct" for accuracy (4.89±0.12) and completeness (4.89±0.11). ChatGPT-4o ranked second (16.73/20), with accuracy (4.22±0.72) and completeness (4.18±0.74) scores significantly higher than those of other models. Claude 3.5 Sonnet and GLM-4 achieved moderate performance (>4.0 for clinical dimensions), whereas Copilot, Gemini 1.5 Flash, and ERNIE 4.0 Turbo showed suboptimal accuracy. Conclusions: DeepSeek-R1 and ChatGPT-4o achieved near-expert accuracy, potentially reliable for basic queries under oversight. Claude 3.5 Sonnet and GLM-4 showed moderate performance with notable gaps. Copilot, Gemini, and ERNIE demonstrated critical errors. However, all models exhibited hallucinated references and a lack of patient-specific reasoning. LLMs should not replace professional medical judgment in treatment decisions. Safe implementation requires restricting high-performing LLMs to narrowly defined procedural questions only, with mandatory physician verification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.